@loriesco
You didn't miss anything. Sorry.
https://www.drugdiscoverytrends.com/fda-approves-removal-of-boxed-warning-from-label-for-osteoporosis-drug-tymlos/
Maximum dosage has changed. Protocal will be slower, as always. The internet has all kinds of outdated material. You'd expect the drug inserts would be updated. The university websites are particularly egregious and they often don't even cite study sources
Too many osteoporosis providers are unaware of the changes and too many don't know how to use bone markers, which I think will be crucial to the understanding of long term Forteo and Tymlos use in individual patients.
The issue is (no longer bone cancer) the anabolic window. At some point on PTH meds the osteoclasts catch up to the osteoblasts because more osteoblastic activitiy stimulates the osteoclasts. Short breaks from Tymlos or Forteo may be the solution.